IMCC (IM Cannabis) 5-Year Yield-on-Cost %: 0.00 (As of Jul. 05, 2026)


IMCC IM Cannabis Corp IMCC
34 GF Score
Price $0.16
GF Value $1.24
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is IM Cannabis 5-Year Yield-on-Cost %?

IM Cannabis IMCC -2.05% 34 5-Year Yield-on-Cost % is 0.00 as of Jul. 05, 2026. GuruFocus rates IMCC with a GF Score™ of 34/100 and a GF Value™ of $1.24 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 517 Drug Manufacturers companies, IM Cannabis ranks worse than 193423.4% on this metric.

IM Cannabis's yield on cost for the quarter that ended in Mar. 2026 was 0.00.


The historical rank and industry rank for IM Cannabis's 5-Year Yield-on-Cost % or its related term are showing as below:



IMCC's 5-Year Yield-on-Cost % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.26
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

IM Cannabis  (NAS:IMCC) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


IM Cannabis 5-Year Yield-on-Cost % Related Terms


IMCC vs BSPK, NPHC, SKYI: 5-Year Yield-on-Cost % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, IM Cannabis's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IM Cannabis 5-Year Yield-on-Cost % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, IM Cannabis's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where IM Cannabis's 5-Year Yield-on-Cost % falls into.


IMCC
34GF Score
IM Cannabis Corp IMCC
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IM Cannabis 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of IM Cannabis is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
IM Cannabis (IMCC) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 05, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on IM Cannabis and its competitors. According to the industry distribution chart, IM Cannabis ranks #999999 out of 517 companies in the Drug Manufacturers industry.
Is IM Cannabis' 5-Year Yield-on-Cost % too high?
IM Cannabis' current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, IM Cannabis ranks #999999 out of 517 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, IM Cannabis has a GF Score™ of 34/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does IM Cannabis' 5-Year Yield-on-Cost % compare to BSPK and NPHC?
According to the Drug Manufacturers industry distribution chart, IM Cannabis ranks #999999 out of 517 companies for 5-Year Yield-on-Cost %. This places IM Cannabis in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.26. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Drug Manufacturers company?
The median 5-Year Yield-on-Cost % among Drug Manufacturers companies is 2.26, based on 517 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on IM Cannabis and its competitors. For the Drug Manufacturers industry, the median 5-Year Yield-on-Cost % is 2.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IM Cannabis's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IM Cannabis stock overvalued right now?
Based on GuruFocus' analysis, IM Cannabis (IMCC) is currently considered Possible Value Trap. The stock's GF Value™ is $1.24, compared to a current price of $0.16 — trading 87.5% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. IM Cannabis' overall GF Score™ is 34/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For IM Cannabis (IMCC), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IM Cannabis (IMCC) Overvalued in 2026?

Based on GuruFocus' analysis, IM Cannabis stock appears to be undervalued. The current stock price of $0.16 is trading 87.5% below its estimated GF Value™ of $1.24. GuruFocus considers IM Cannabis to be Possible Value Trap.

Key valuation signals for IMCC:

  • 5-Year Yield-on-Cost %: 0.00
  • GF Value™: $1.24 vs. price of $0.16 (87.5% below fair value)
  • GF Score™: 34/100 with 8 warning signs

No single metric tells the full story. See the IMCC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


IM Cannabis Business Description

Address Central District, Kibbutz Glil Yam, ISR, 4690500
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority revenue is generated from Germany, and also has its presence in Israel.
34GF Score

Get the complete analysis for IMCC

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.16
Price
$1.24
GF Value